Surgical Equipment and Services

Full CE certification for TriboFit Hip System

The use of polycarbonate-urethane as a hip joint bearing material gains CE Class III certification for the TiboFit system from Active Implants

07 September 2009: Active Implants

Radial head plates demonstrated at Hand Surgery convention

Medartis is offering hand surgeons the opportunity to work with the company’s innovative fixation for radial head fractures at the American Society for Surgery of the Hand meeting in San Francisco

07 September 2009: Medartis

FDA Clearance for spinal fixation system

Spinal system for the correction of long and complex deformities and curvatures gains FDA clearance opening up the US market to Medicrea

07 September 2009: Medicrea

Respirator mask volume increase prior to flu season

Alpha Pro Tech is planning to triple output of its N-95 disposable respirator masks for health care professionals in advance of the flu season taking hold

04 September 2009: Alpha Pro Tech

Coronary Stent system launched internationally

Abbott Vascular has gone international with its Xience Prime Drug Eluting Coronary Stent for treating coronary disease

02 September 2009: Abbott Vascular

Prescient's vProtect Luminal Shield Stent receives CE Mark

Prescient Medical receives European CE Mark approval to commercialize its vProtect Luminal Shield Stent System which is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischaemic heart disease.

25 August 2009: Prescient Medical

HeartWare passes implant clinical trial milestone

HeartWare International surpasses 50 implants in the USA under its ADVANCE Clinical Trial, marking an early enrollment milestone.

24 August 2009: HeartWare

Abbott receives Health Canada approval for the Xience V stent to treat CAD

Abbott receives approval from Health Canada for the Xience V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD).

24 August 2009: Abbott Vascular

Skandionkliniken selects Varian to equip new Swedish proton therapy centre

Varian Medical Systems is selected to equip a new proton therapy centre in Sweden.

21 August 2009: Varian

Medtronic launches Distractible End Cleats System in the USA

Medtronic launches the T2 SCEPTOR Distractible End Cleats System in the US market.

14 August 2009: Medtronic

Xience V USA post-approval study is expanded

Abbott expands the company's Xience V USA post-approval study designed to evaluate the safety and effectiveness of the company's market-leading XIENCE V Everolimus Eluting Coronary Stent System in a real-world clinical setting out to five years.

14 August 2009: Abbott Vascular

Polymer-free Zilver PTX drug-eluting peripheral stent completes European patient implants

Physicians in Europe complete patient implants of the first CE Mark approved drug-eluting stent designed specifically to treat severe blockages in the challenging and largest artery in the leg.

13 August 2009: Cook

Turkish hospital group purchases four radiotherapy treatment units from Varian

The first hospital group in Turkey to offer cancer patients advanced RapidArc radiotherapy treatments has acquired four additional treatment machines from Varian Medical Systems.

12 August 2009: Varian

University Hospital Munich deploys advanced IMRT planning tool for cancer treatment

The University Hospital Munich, Ludwig Maximilians-University (LMU) has delivered clinical treatments to cancer patients utilising Monaco, an advanced Intensity Modulated Radiotherapy (IMRT) planning solution from Elekta CMS Software.

12 August 2009: Elekta

Barts and The London NHS Trust installs quartet of radiotherapy treatment units

Developers behind a project to redevelop one of London's leading cancer centres order four new radiotherapy treatment machines from Varian Medical Systems.

06 August 2009: Varian

Accuray launches real-time customer service for CyberKnife Robotic Radiosurgery System

Accuray launches the CyberKnife Access Remote Service product, a real-time customer service and support offering for the CyberKnife Robotic Radiosurgery System.

27 July 2009: Accuray

Elekta’s VMAT Monaco treatment planning solution receives 510(k) clearance

Elekta receives FDA 510(k) clearance for the VMAT (Volumetric Modulated Arc Therapy) enhancement to Monaco, treatment planning solution.

27 July 2009: Elekta

Radiosurgery Center of Rhode Island installs robotic radiosurgery system

Radiosurgery Center of Rhode Island, installs a CyberKnife Robotic Radiosurgery System from Accuray within Rhode Island Hospital in Providence, which marks the first CyberKnife System in Rhode Island.

24 July 2009: Accuray

Elekta selects C-RAD laser scanner system for patient positioning demands

Elekta and C-RAD reach an agreement where the Sentinel laser scanner system has been selected as the Elekta preferred solution for optical surface tracking.

23 July 2009: Elekta

ATS Medical deploys surgical cryoblation probe to treat cardiac arrhythmias

ATS Medical announces the first commercial use of the new ATS CryoMaze 10-S Surgical Cryoablation Probe for the treatment of cardiac arrhythmias.

22 July 2009: ATS Medical

Space Coast Cancer Center delivers image-guided radiotherapy to speed treatment

Doctors at the Space Coast Cancer Center in Titusville, Florida are using RapidArc radiotherapy technology from Varian Medical System to deliver image-guided radiotherapy that precisely conforms to a targeted area two to eight times faster than was previously possible.

21 July 2009: Varian

Beijing Cancer Hospital deploys RapidArc radiotherapy technology

Cancer patients in mainland China are gaining access to fast, efficient radiotherapy treatments with the introduction of RapidArc radiotherapy technology from Varian Medical Systems at the Beijing Cancer Hospital.

20 July 2009: Varian

Juntendo University treats prostate patients with new VMAT technology

Juntendo University (Tokyo, Japan) is the third facility in Japan to begin using Elekta Synergy to treat prostate patients with Volumetric Modulated Arc Therapy (VMAT).

17 July 2009: Elekta

US FDA approves Boston's Taxus Liberte Long Paclitaxel-Eluting Coronary Stent

Boston Scientific receives approval from the US Food and Drug Administration (FDA) to market its Taxus Liberte Long Paclitaxel-Eluting Coronary Stent System, a next-generation drug-eluting stent (DES) designed for long lesions.

17 July 2009: Boston Scientific

Life Spine’s FS3 minimally invasive spinal system receives 510(k) clearance

The US Food and Drug Administration (FDA) gives 510(k) marketing clearance to Life Spine’s FS3 Minimally Invasive Spinal System.

10 July 2009: Life Spine